IT1091303B - Fenossi-ammino-propanoli e procedimento per la loro produzione - Google Patents

Fenossi-ammino-propanoli e procedimento per la loro produzione

Info

Publication number
IT1091303B
IT1091303B IT51335/77A IT5133577A IT1091303B IT 1091303 B IT1091303 B IT 1091303B IT 51335/77 A IT51335/77 A IT 51335/77A IT 5133577 A IT5133577 A IT 5133577A IT 1091303 B IT1091303 B IT 1091303B
Authority
IT
Italy
Prior art keywords
propanols
phenoxy
amino
procedure
production
Prior art date
Application number
IT51335/77A
Other languages
English (en)
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of IT1091303B publication Critical patent/IT1091303B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58Radicals substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
IT51335/77A 1976-10-09 1977-10-07 Fenossi-ammino-propanoli e procedimento per la loro produzione IT1091303B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2645710A DE2645710C2 (de) 1976-10-09 1976-10-09 Phenoxy-amino-propanole, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitung

Publications (1)

Publication Number Publication Date
IT1091303B true IT1091303B (it) 1985-07-06

Family

ID=5990109

Family Applications (1)

Application Number Title Priority Date Filing Date
IT51335/77A IT1091303B (it) 1976-10-09 1977-10-07 Fenossi-ammino-propanoli e procedimento per la loro produzione

Country Status (21)

Country Link
US (2) US4171370A (it)
JP (1) JPS5346930A (it)
AT (1) AT357143B (it)
AU (1) AU520307B2 (it)
BE (1) BE859425A (it)
CA (1) CA1110253A (it)
CH (1) CH630337A5 (it)
DE (1) DE2645710C2 (it)
ES (1) ES463022A1 (it)
FR (1) FR2367053A1 (it)
GB (1) GB1532380A (it)
HK (1) HK39483A (it)
HU (1) HU177868B (it)
IL (1) IL53063A (it)
IT (1) IT1091303B (it)
NL (2) NL185665C (it)
PT (1) PT67083B (it)
SE (1) SE441827B (it)
SG (1) SG7192G (it)
YU (1) YU40820B (it)
ZA (1) ZA776018B (it)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55124742A (en) * 1979-03-20 1980-09-26 Kyowa Hakko Kogyo Co Ltd Novel aminoalcohol derivative
JPS56144222A (en) * 1980-04-10 1981-11-10 Teijin Ltd False twisted crimped yarn
DE3125870C2 (de) * 1980-07-09 1994-09-15 William John Louis 3-Aminopropoxyphenyl Derivate, ihre Herstellung und sie enthaltende Arzneimittel
US4472427A (en) * 1980-12-23 1984-09-18 Merck & Co., Inc. (Aralkylamino-2-OR-propoxy)heterocyclic compounds
DE3125636A1 (de) * 1981-06-30 1983-01-13 Merck Patent Gmbh, 6100 Darmstadt 1-(p-2-isopropoxyethoxymethyl-phenoxy)-3-isopropylamino-propan-2-ol zur senkung des augeninnendrucks und ophtalmikum, enthalten diese verbindung
FR2512443A1 (fr) * 1981-09-10 1983-03-11 Synthelabo Derives de phenoxy-3 propanol-2, leur preparation et leur application en therapeutique
JPS5891855A (ja) * 1981-11-27 1983-05-31 株式会社クラレ 寝装用ポリエステル繊維ステープル綿およびその製造法
DE3151201A1 (de) * 1981-12-23 1983-07-28 Beiersdorf Ag, 2000 Hamburg Substituierte phenoxyalkanolamine und phenoxyalkanol-cycloalkylamine, verfahren zu ihrer herstellung, diese verbindungen enthaltende pharmazeutische zubereitungen und zwischenprodukte
CA1262729A (en) * 1983-10-19 1989-11-07 Leo Alig Phenoxypropanolamines
US5166218A (en) * 1983-10-19 1992-11-24 Hoffmann-La Roche Inc. Phenoxypropanolamines and pharmaceutical compositions thereof
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
GB8419683D0 (en) * 1984-08-02 1984-09-05 Erba Farmitalia 3-substituted derivatives of 1-amino-2-hydroxy-propane
US4665094A (en) * 1985-08-29 1987-05-12 Merck & Co., Inc. Oculoselective beta-blockers for treatment of elevated intraocular pressure
US4945182A (en) * 1985-12-24 1990-07-31 Merck & Co., Inc. Oculoselective beta-blockers
JPH01501797A (ja) * 1987-03-16 1989-06-22 ユニヴァーシティ オブ フロリダ 3―置換―1―アルキルアミノ―2―プロパノールの不安定なケトン誘導体と、そのβ―アドレナリン作動効果遮断薬としての応用
DE3866984D1 (en) * 1987-07-21 1992-01-30 Hoffmann La Roche Phenoxypropanolamine.
ES2011584A6 (es) * 1989-05-26 1990-01-16 Esteve Quimica Sa Procedimiento industrial para la obtencion de una ariloxipropanolamina.
DE3920369A1 (de) * 1989-06-22 1991-01-10 Merck Patent Gmbh Migraenemittel
US5217994A (en) * 1991-08-09 1993-06-08 Merck & Co., Inc. Method of inhibiting osteoclast-mediated bone resorption by administration of aminoalkyl-substituted phenyl derivatives
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
ATE215369T1 (de) 1996-09-05 2002-04-15 Lilly Co Eli Carbazolanaloge als selektive beta3-adrenergische agonisten
US5808080A (en) * 1996-09-05 1998-09-15 Eli Lilly And Company Selective β3 adrenergic agonists
CO5011072A1 (es) 1997-12-05 2001-02-28 Lilly Co Eli Etanolaminas pirazinil substituidas como agfonistas de los receptores
CN100338026C (zh) * 2002-07-12 2007-09-19 北京四环医药科技股份有限公司 制备比索洛尔及其盐的改进方法
RS20050106A (en) 2002-08-19 2007-11-15 Pfizer Products Inc., Combination therapy for hyperproliferative diseases
KR20090053867A (ko) * 2003-01-14 2009-05-27 길리애드 사이언시즈, 인코포레이티드 복합 항바이러스 치료를 위한 조성물 및 방법
CA2753318A1 (en) * 2003-05-30 2004-12-09 Ranbaxy Laboratories Limited Substituted pyrrole derivatives
US20060281818A1 (en) * 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
EP1948599A1 (en) * 2005-11-08 2008-07-30 Ranbaxy Laboratories Limited Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US20070238716A1 (en) * 2006-03-14 2007-10-11 Murthy Ayanampudi S R Statin stabilizing dosage formulations
JP2009543773A (ja) * 2006-07-14 2009-12-10 ランバクシー ラボラトリーズ リミテッド HMG−CoAレダクターゼ阻害剤の多形体及びその使用
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
WO2008112287A1 (en) 2007-03-12 2008-09-18 Nektar Therapeutics Oligomer-beta blocker conjugates
US10849863B2 (en) 2011-04-28 2020-12-01 University Of Louisville Research Foundation, Inc. Compounds for treating cancer, for administering, and for pharmaceutical compositions
WO2014170786A1 (en) 2013-04-17 2014-10-23 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof
GB202102575D0 (en) 2021-02-23 2021-04-07 Teva Pharmaceutical Industries Ltd Fixed-dose pharmaceutical compositions

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH465640A (de) * 1964-09-10 1968-11-30 Ciba Geigy Verfahren zur Herstellung neuer Amine
US3483221A (en) * 1964-09-10 1969-12-09 Ciba Geigy Corp 1 - (isopropylamino)-2-hydroxy-3-(alkenyloxyphenoxy) - propanes and the salts thereof
NL163775C (nl) * 1967-12-18 1980-10-15 Boehringer Sohn Ingelheim Werkwijze ter bereiding van farmaceutische preparaten met beta-receptoren blokkerende werking, alsmede werkwijze ter bereiding van 1-(cyaanfenoxy)-2-hydroxy-3-(sec.alkylamino) propaanderivaten.
GB1285038A (en) * 1969-02-21 1972-08-09 Ici Ltd Alkanolamine derivatives
DE2065985A1 (de) * 1969-05-16 1977-08-04 Yoshitomi Pharmaceutical Phenoxyaminopropanolverbindungen
SE372762B (it) * 1969-05-21 1975-01-13 Haessle Ab
GB1276968A (en) * 1970-01-15 1972-06-07 Lepetit Spa Improvements in or relating to phenylacetamides and the preparation thereof
SE354851B (it) * 1970-02-18 1973-03-26 Haessle Ab
US3929856A (en) * 1971-12-14 1975-12-30 Parke Davis & Co 1-(3,4-Dimethoxyphenethylamino)-3-(phenoxy)-2-propanols
US4145442A (en) * 1972-04-04 1979-03-20 Aktiebolaget Hassle Phenoxy-hydroxypropylamines, their preparation, and method and pharmaceutical preparations for treating cardiovascular diseases
SE386892B (sv) * 1972-07-06 1976-08-23 Haessle Ab Forfarande for framstellning av oxaminoforeningar
US4084002A (en) * 1973-02-28 1978-04-11 Boehringer Ingelheim Gmbh Pharmaceutical compositions containing a 1-phenoxy-2-hydroxy-3-alkynylamino-propane and method of use
US3966770A (en) * 1975-03-25 1976-06-29 Smithkline Corporation 4-Hydroxy-α-[(3,4-methylenedioxyphenyl)isopropylaminoethyl]-3-(methylsulfonylmethyl)benzyl alcohol
US4067904A (en) * 1975-12-19 1978-01-10 Mead Johnson & Company Alkylsulfonylphenoxypropanolamine derivatives

Also Published As

Publication number Publication date
SE7711278L (sv) 1978-04-10
US4171370A (en) 1979-10-16
ES463022A1 (es) 1978-12-16
YU236877A (en) 1983-01-21
AU2946477A (en) 1979-04-12
IL53063A0 (en) 1977-12-30
SG7192G (en) 1992-07-24
CA1110253A (en) 1981-10-06
IL53063A (en) 1981-06-29
ATA717377A (de) 1979-11-15
NL930020I1 (nl) 1993-05-03
CH630337A5 (de) 1982-06-15
PT67083A (de) 1977-10-01
US4258062A (en) 1981-03-24
PT67083B (de) 1979-02-22
NL930020I2 (nl) 1993-09-16
SE441827B (sv) 1985-11-11
NL185665B (nl) 1990-01-16
FR2367053B1 (it) 1981-11-27
NL7711042A (nl) 1978-04-11
JPS5346930A (en) 1978-04-27
FR2367053A1 (fr) 1978-05-05
AU520307B2 (en) 1982-01-28
NL185665C (nl) 1990-06-18
BE859425A (nl) 1978-04-06
JPS6210220B2 (it) 1987-03-05
ZA776018B (en) 1978-05-30
GB1532380A (en) 1978-11-15
HU177868B (en) 1982-01-28
DE2645710C2 (de) 1985-06-27
AT357143B (de) 1980-06-25
DE2645710A1 (de) 1978-04-13
YU40820B (en) 1986-06-30
HK39483A (en) 1983-10-13

Similar Documents

Publication Publication Date Title
IT1091303B (it) Fenossi-ammino-propanoli e procedimento per la loro produzione
IT1090497B (it) Poliretan-poliuree e procedimento per la loro produzione ed applicazione
IT1106424B (it) Agenti antielmintici e procedimenti per la loro produzione
IT1092262B (it) Spirolattoni e procedimento per la loro preparazione
IT7850153A0 (it) Poliureto-poliisocianati e procedimento per la loro produzione ed applicazione
IT1079804B (it) Benzofuranil-benzimidazoli e procedimento per la loro produzione ed applicazione
IT1106421B (it) Tideteri basici e procedimento per la loro produzione
IT1073611B (it) Bis tetraalogenoftalati alchilen diammonici e procedimento per la loro preparazione
IT1091124B (it) Miscugli contenenti diorganopolisi lossani e procedimento per la loro produzione ed applicazione
IT1104811B (it) Piperidil-solfonammidi sostituite e procedimento per la loro produzione
IT1076946B (it) Diidroossadiazinoni e procedimento per la loro fabbricazione
IT1075298B (it) Aminoalchilpirrolbenzossazalcani e metodo per la loro preparazione
IT1075299B (it) Pirrolbenzossazalcani e metodo per la loro preparazione
IT1085546B (it) Benzensolfoniluree e processo per la loro preparazione
IT1053876B (it) Isocianati e procedimento per la loro produzione
IT1077193B (it) 1-arilossi-2-idrossi-3-aminopropani e processo per la loro preparazione
IT1111353B (it) Alcossisilani polimerici e procedimento per la loro produzione ed applicazione
IT1083165B (it) Tri-isocianati e procedimento per la loro produzione ed applicazione
IT1090310B (it) Composti aralifatici anionici e procedimento per la loro produzione e loro applicazione
IT1086270B (it) Uracil-derivati e procedimento per la loro preparazione
IT7948361A0 (it) Dialogenocomposti aralifatici e procedimento per la loro produzione
IT1121684B (it) Isossazoli e procedimento per la loro produzione
IT7850705A0 (it) Bistiazoli sostituiti e procedimento per la loro produzione
IT1106239B (it) Aril-tiocarbossilati tiocianometilici e procedimento per la loro produzione e applicazione
IT7848157A0 (it) Aril-esafuranosidi e procedimento per la loro produzione ed applicazione

Legal Events

Date Code Title Description
ITCP Complementary protection certificate

Free format text: CCP 197

MEDD Supplementary protection certificate for pharmaceutical products: granted

Free format text: CCP 197, 19920429; MERCK PATENT GESELLSCHAFT MIT BESCH RANKTER HAFTUNG

TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19941027